59 results
8-K
EX-10.1
EGRX
Eagle Pharmaceuticals Inc
8 Mar 24
Departure of Directors or Certain Officers
4:49pm
but not limited to the 2010 Patient Protection and Affordable Care Act, as amended by the 2010 Health Care and Education Reconciliation Act), then provided
8-K
EX-99.1
EGRX
Eagle Pharmaceuticals Inc
27 Sep 23
Regulation FD Disclosure
7:00am
with Barhemsys or Byfavo during the second quarter of 2023 275 health care facilities purchased the products out of a total targeted market of approximately
8-K
EX-99.1
EGRX
Eagle Pharmaceuticals Inc
7 Sep 23
Regulation FD Disclosure
7:20am
with Barhemsys or Byfavo during the second quarter of 2023 275 health care facilities purchased the products out of a total targeted market
8-K
EX-99.1
qmopjjhevtxej9c40hvz
8 Aug 23
Eagle Pharmaceuticals Reports Second Quarter 2023 Results
7:06am
8-K
EX-99.1
n468ufhnuhy9sme
6 Jun 23
Regulation FD Disclosure
8:23pm
8-K
EX-10.1
d7op7l9xb2etyz
9 Dec 22
Departure of Directors or Certain Officers
5:13pm
8-K
EX-99.1
r4c4v70yvky829eu
6 Dec 22
Regulation FD Disclosure
7:31am
8-K
EX-10.1
giz6d10uoiq251llp1jn
9 Aug 22
Eagle Pharmaceuticals Reports Second Quarter 2022 Results
8:26am
8-K
EX-2.2
t288xf9gh8
28 Mar 22
Eagle Pharmaceuticals Agrees to Terms to Acquire Acacia Pharma Group plc
6:04am
8-K
EX-99.1
xs1cj1212naowqp9uof
11 Jan 22
Regulation FD Disclosure
11:45am
8-K
EX-99.1
aavkd9mfw7 8wn
14 Oct 21
Regulation FD Disclosure
8:01am